Does age matter in the selection of treatment for men with early-stage prostate cancer?

Cancer

Volumn 106, Issue 12, 2006, Pages 2598-2602

  Konski, Andre ^a   Eisenberg, Debra ^a   Horwitz, Eric ^a   Hanlon, Alexandra ^a   Pollack, Alan ^a   Hanks, Gerald ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Age; Early stage; External beam radiation therapy; Prostate cancer; Survival

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; DISEASE FREE SURVIVAL; EARLY CANCER; GLEASON SCORE; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; RADIATION DOSE; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMBINED MODALITY THERAPY; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY, CONFORMAL; SURVIVAL ANALYSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33745204706     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.21923     Document Type: Article

References (18)

1. Freedman GM, Hanlon AL, Lee WR, Hanks GE. Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation. Int J Radiat Oncol Biol Phys. 1996;35:243-250.
2. Hanks GE, Hanlon AL, Horwitz EM. Evidence for cure of "young" men with prostate cancer. Oncology (Williston Park). 2001;15:563-567; discussion, 71-74.
3. Zelefsky MJ, Marion C, Fuks Z, Leibel SA. Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapy. J Urol. 2003;170:1828-1832.
4. [no authors listed]. Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel. Int J Radiat Oncol Biol Phys. 1997;37:1035-1041.
5. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:447-457.
6. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep. 1966;50:163-170.
7. Grabstald H. Radical treatment for all but exceptional cases. Issues Curr Med Pract. 1966;3:10.
8. Rosenberg S. Is carcinoma of the prostate less serious in older men? J Am Geriatr Soc. 1965;13:791-798.
9. Cook GB, Watson FR. A comparison by age of death rates due to prostate cancer alone. J Urol. 1968;100:669-671.
10. Johnstone PA, Riffenburgh RH, Moul JW, et al. Effect of age on biochemical disease-free outcome in patients with T1-T3 prostate cancer treated with definitive radiotherapy in an equal-access health care system: a radiation oncology report of the Department of Defense Center for Prostate Disease Research. Int J Radiat Oncol Biol Phys. 2003;55:964-969.
11. Austin JP, Convery K. Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation. Am J Clin Oncol. 1993;16:140-145.
12. Kerr LA, Zincke H. Radical retropubic prostatectomy for prostate cancer in the elderly and the young: complications and prognosis. Eur Urol. 1994;25:305-311; discussion, 11-12.
13. Khan MA, Han M, Partin AW, Epstein JI, Walsh PC. Long-term cancer control of radical prostatectomy in men younger than 50 years of age: update 2003. Urology. 2003; 62:86-91; discussion, 91-92.
14. Merrill RM, Bird JS. Effect of young age on prostate cancer survival: a population-based assessment (United States). Cancer Causes Control. 2002;13:435-443.
15. Rosser CJ, Chichakli R, Levy LB, Kuban DA, Smith LG, Pisters LL. Biochemical disease-free survival in men younger than 60 years with prostate cancer treated with external beam radiation. J Urol. 2002;168:536-541.
16. Kupelian PA, Potters L, Khuntia D, et al. Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys. 2004; 58:25-33.
17. Cavanaugh SX, Fuller CD, Kupelian PA, et al. Time and PSA threshold model prognosticates long-term overall and disease-specific survival in prostate cancer patients as early as 3 months after external beam radiation therapy. Prostate Cancer Prostatic Dis. 2005;8:353-358.
18. Kamat AM, Rosser CJ, Levy LB, et al. Rise in serum PSA of 1.5 ng/mL above 24-month nadir after external beam radiotherapy is predictive of biochemical failure. Urology. 2004; 63:1132-1137.